This #BlackHistoryMonth, AASLD spotlights the role of public policy in advancing #liverhealth equity. Evidence-based policies are essential to expanding access to prevention, early diagnosis, and treatment of liver diseases. ➡️ Learn more: https://bit.ly/4ckbExT

📙Explore the latest Practice Guideline from #AASLD and American Society of Transplantation, published in #LiverTransplantation. ➡️ Read more: https://bit.ly/4anvTNt

AASLD’s 2026 Transplant Hepatology Fellowship Matching is still accepting applications! Tailor your experience and use AASLD as your agent in matching you with an invaluable fellowship. Start your application! https://bit.ly/3oQOYQo

🔥HOT TOPIC in #HepatologyCommunications A new systematic review of 68 randomized trials suggests albumin infusion in cirrhosis may reduce mortality & complications, while highlighting the need for more rigorous evidence to fully understand its benefits & risks. 💻Full study: https://bit.ly/4qV49p9

This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care. #Gastroenterology Nurse Practitioner Pamela Barr, MSN, FNP-C is passionate about providing high-quality, patient-centered care across the lifespan, with a focus on serving underserved communities.

Co-Editors-in-Chief Elliot B. Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the February issue of #HepatologyCommunications. Watch below and view the latest issue here: https://bit.ly/4sf5gBm https://www.youtube.com/watch?v=AOUNOg3JYew

This #ValentinesDay, we’re celebrating the heart of our community, the dedicated members of #AASLD. ❤️ Thank you for all you do to advance #hepatology, promote #liverhealth, and transform lives through quality patient care.

One Month Out! The AASLD Emerging Topic Conference (ETC) is designed to examine how interconnected evidence across #liverdisease informs clinical and translational decision-making. View the program and register: https://bit.ly/3KHXpeG

🔥 HOT TOPIC in #HEPATOLOGY This landmark study shows that vibration-controlled transient elastography provides prognostic accuracy comparable to histology in #MASLD, supporting liver stiffness measurement as a noninvasive surrogate endpoint for clinical trials. 📗Read more: https://bit.ly/4c7gulx

This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care. Julius M. Wilder, MD, PhD, Chair of the #AASLD Public Policy Committee, shares how research, advocacy, and evidence-based policy can drive real progress toward health equity.

This #BlackHistoryMonth, AASLD spotlights members whose work advances science, equity, and care. Rotonya Carr, MD, FACP, FAASLD shares an important message on the resilience of our #hepatology field and the legacy of Black leadership in medicine.

@who.int is considering expanding its NCD definition to include liver disease, reflecting growing recognition of liver health as central to integrated, lifelong care and prevention. AASLD welcomes this important step for global liver health! Learn more: https://bit.ly/4ckbExT

Your perfect match starts with AASLD’s Transplant Hepatology Fellowship Matching Program! Let AASLD be your agent in matching with reputable institutions and mentors in #transplant hepatology — apply now. https://bit.ly/3oQOYQo

Don’t miss the #WorldHepatitisSummit 2026 held in Bangkok, Thailand on Apr. 28-30. Register by Feb. 24 to secure early bird rates. https://bit.ly/4sEMDXN

View the first message of the year from 2026 #AASLD President Dr. Saul Karpen! https://bit.ly/4a43mLz

Join us in ONE HOUR for this valuable webinar! Claim your spot to identify the indications, limitations, and the application of TIPS in patients with #cirrhosis and variceal bleeding. Claim my spot. https://bit.ly/49Yljv5

Introducing the new #AASLD Publications Showcase Page on LinkedIn! Stay current on the leading science and practice-changing studies across #HEPATOLOGY, #LiverTransplantation, and #HepatologyCommunications. 🔗Explore the new page here: https://bit.ly/3LHzv3o.

Moderated by Virginia Hernandez-Gea, MD, PhD, be part of the discussion on the differences between rescue versus pre-emptive TIPS in patients with #cirrhosis and variceal bleeding. Register now for the January 27 webinar. https://bit.ly/49Yljv5

This must-read resource brings together the latest recommendations on immunosuppression, rejection, recurrent disease, and emerging advances to support optimal long-term outcomes and elevate the future of transplant care. ➡️ Read more in #LiverTransplantation: https://bit.ly/3NzlIwj.

⚠️ We need your help! Contact your senators today and urge them to pass the FY26 Labor–HHS appropriations bill to ensure predictable funding for NIH, CDC, and other critical health agencies. 📩 Take action now using the #AASLD Policy Action Center: https://bit.ly/3YVavso. #FY26Budget

Thank you to AASLD Past President Dr. Grace L. Su and @endocrinesociety.bsky.social for raising awareness today on Capitol Hill! #AASLD continues to advocate and educate to promote #liverhealth and quality patient care. Learn more about AASLD’s public policy work here: https://bit.ly/4ckbExT.

Representatives from #AASLD, including AASLD Past President Grace L. Su, MD, FAASLD, speak with Congressman John Moolenaar to share how #GLP1 therapies are redefining the standard of care for #obesity and #liverdisease.

#AASLD Past President Grace L. Su, MD, FAASLD speaks about how #obesity impacts #liver health during the Congressional Briefing.

🏛 Happening now on Capitol Hill! #AASLD and @endocrinesociety.bsky.social#AASLDare hosting a Congressional Briefing to educate lawmakers on how #obesity impacts the #liver, including how #GLP1s are a game changer for the treatment of obesity and #liverdisease.

#AASLD President Saul Karpen speaking at The Best of #TLM25: AASLD & Saudi Society for the Study of Liver Diseases at the #SASLT Conference 2026 in Riyadh, Saudi Arabia.

📰 AASLD IN THE NEWS: In this @gohealio.bsky.social interview, #AASLD President Dr. Saul Karpen discusses the updated 2025-2030 Dietary Guidelines for Americans and what #gastroenterologists and #hepatologists should consider when discussing them with patients. Read: https://bit.ly/4jJtSxW.

Co-Editors-in-Chief Elliot B. Tapper, MD, FAASLD, and Carmen Chak-Lui Wong, PhD, share highlights from the January issue of #HepatologyCommunications. Watch below and view the latest issue here: https://bit.ly/4sf5gBm. https://www.youtube.com/watch?v=rZg9XmYbk7I

The Hepatotoxicity SIG will host its first 2026 seminar, focusing on liver safety of GLP-1 RA's. As semaglutide was the first GLP-1 receptor agonist (GLP-1RA) to be approved for #MASH with #fibrosis, you don't want to miss this in-depth discussion on advancements. Register at https://bit.ly/45aUlyy

Are you involved in the management of patients with portal hypertension? Attend the upcoming Jan. 27 webinar and learn how to identify the indications, limitations, and the application of TIPS in patients with #cirrhosis and variceal bleeding. Register today. https://bit.ly/49Yljv5

Despite 2025-2030 Dietary Guidelines for Americans changes, #AASLD will continue to educate the public about the impact of alcohol consumption on #liverhealth. View our statement here: https://bit.ly/45I3wXr.

Tomorrow join us for this impactful mid-career webinar! Save your seat to discuss career challenges, how to network and identify opportunities, and renew your sense of purpose in your career. Save your seat — register now. https://bit.ly/45cuoyt

The revised Dietary Guidelines recently removed evidence-based alcohol guidance, leaving Americans without necessary information to make informed health decisions. Read AASLD's statement: www.aasld.org/aasld-raises-concern-over-removal-evidence-based-alcohol-guidance-2025-2030-dietary-guidelines

AASLD President, Dr. Saul Karpen, was featured in a MedPage Today article this week highlighting ongoing national discussions and debate around childhood vaccination recommendations in the U.S. Click the link to read the article: https://bit.ly/49Ky6lI.

Together, we made an impact in 2025. #ICYMI Dive into the #AASLD Year in Review and SIG & Committee End-of-Year Impact Update to learn more. https://bit.ly/3KIF6WM

There is still time to submit a late breaker abstract for the #WorldHepatitisSummit 2026 in Bangkok, Thailand! Submit an abstract by Jan.15. #WHS2026 https://bit.ly/4pkaJnu

🎉 Happy New Year! Together, we’re ready to reach new heights in #hepatology in 2026.

⏰ Last chance #TLM25 attendees! Tomorrow is the final day to claim your CME credits and access all the sessions on TLMdX. Claim your credits here: https://bit.ly/3ZLRPLw Revisit sessions here: https://bit.ly/4ofhHK1 #Hepatology #MedicalInnovation #LiverResearch

In 2025, AASLD members moved the field of #hepatology forward. Explore our 2025 Year in Review and the End-of-Year Impact Update, featuring our SIG & Committee accomplishments here: https://bit.ly/3KIF6WM

Embrace new challenges and find renewed purpose in your career with this January 13 webinar! Learn how to identify life-changing opportunities, build strong professional relationships, and optimize your career growth as a mid-career professional. Register now. https://bit.ly/45cuoyt

Co-Editors-in-Chief Drs. Elliot B. Tapper & Carmen Chak-Lui Wong share exciting science from the December issue of #HepatologyCommunications including #AI, #MASLD, #HCC, #ThyroidDisease, #MASH, & more. 🔗View the latest issue here: https://bit.ly/4sf5gBm https://www.youtube.com/watch?v=-oJWMJWcOa8

That’s a wrap! The 2025 EASL-AASLD Masterclass brought early-career investigators together for three immersive days of learning, collaboration, and career-shaping conversations at the beautiful Château de Bellinglise in France.

📙Read the latest Policy Corner from #LiverTransplantation: #AI could improve equity, matching, and outcomes, but inconsistent governance and biased data pose challenges. Learn why clear principles are needed now. 🔗 https://bit.ly/4p4CVdT

Happy holidays from AASLD!

Strong science starts with rigorous peer review. Thank you to the 2025 top reviewers of #HEPATOLOGY, #LiverTransplantation, and #HepatologyCommunications.

It’s the people who make #TLM25 unforgettable! Looking back at the conversations, collaborations, and shared discoveries, we’re reminded of the incredible power of our global hepatology community. #HepatologyCommunity #LiverDoctors

CDC accepted changes to the #HepatitisB birth dose—despite decades of evidence showing it prevents up to 95% of new infections. Ahead of the Dec. ACIP vote, #AASLD members sent nearly 1,200 letters to protect this lifesaving policy. We’ll keep fighting for patients & science. 🔗https://bit.ly/4alSKcH

Pro vs. Con: Check out the latest Controversies in #LiverTransplantation Corner Should the OPTN shift to a multi-vendor model? Reply to share your thoughts! 🟢 Pro: bit.ly/45codug 🔴 Con: bit.ly/4aWyy17

Moderated by Harmeet Malhi, MBBS, FAASLD and Tatyana Kushner, MD, MSCE, join us for Part Two: Mid-career Muddle, and learn how you can revitalize passion for your career and take control of your professional growth through networking. Register today. https://bit.ly/45cuoyt

Don’t forget to claim your CME credits for the sessions you completed at #TLM25! Visit the link and complete your submission by December 31. https://bit.ly/3ZLRPLw #Hepatology #LiverResearch

🚨Now Online! #AASLD and American Society of Transplantation announce two new Practice Guidelines HEPATOLOGY: Adult #LiverTransplantation: Candidate Evaluation https://bit.ly/44TAhAP Liver Transplantation: Post-Transplant Management of Non-Graft-Related Complications https://bit.ly/4oYX3OM